Cardiac imaging of either myocardial perfusion or regional function, under resting and stress conditions, utilizing either nuclear cardiology or ultrasound technology, is the dominant approach to the noninvasive detection of coronary artery disease (CAD) in symptomatic patients. Prior to the advent of imaging technology that permitted assessment of myocardial perfusion and function, symptom-limited exercise electrocardiography (ExECG) alone was the test employed for detecting CAD. Multiple clinical studies showed that combining imaging with symptomlimited exercise enhanced the diagnostic and prognostic values of exercise testing, over the variables derived from ExECG. Pharmacologic stress then emerged as an alternative to exercise for imaging of patients who were deemed unable to attain a target heart rate of C85% of maximum predicted heart rate adjusted for age. Submaximal exercise decreases the sensitivity of MPI for detection of ischemia and prevents accurate measurement of extent of ischemia when present.
1With either SPECT or PET myocardial perfusion imaging (MPI), intravenously administered vasodilators such as dipyridamole, adenosine, and regadenoson substituted as stressors for exercise. These agents allowed for detection of relative flow reserve alterations between stenotic and normal coronary arteries. Dobutamine infusion was reserved for patients with bronchospasm, or those who ingested caffeine prior to testing. For stress echocardiography, dobutamine emerged as the major pharmacologic alternative to exercise stress. New ischemia-induced wall motion abnormalities constituted a positive test for ischemia. Sensitivity for CAD detection is higher, and specificity lower, for stress MPI compared to stress echocardiography. For this reason, stress echocardiography is commonly performed in patients at lower pre-test clinical risk for CAD. Conversely, with a higher sensitivity for CAD detection, stress MPI is advocated for higher risk patients with suspected or known CAD who need testing for appropriate clinical indications.Over the past few decades, the percentage of patients referred for pharmacologic stress imaging, relative to exercise imaging, has been increasing from about 30% to more than 50% of stress imaging tests.
2,3In addition, a substantial number of patients initially referred for exercise stress are being triaged to pharmacologic stress. Patients who are unable to achieve target heart rate with exercise are changed over to predominantly vasodilator stress for the injection of tracer for radionuclide imaging, or dobutamine infusion for completion of stress echocardiographic testing. Currently, patients referred for PET MPI all undergo pharmacologic stress since the positron-emitting tracers (e.g., Rb-82) approved for clinical imaging have very short half-lives, thereby precluding upright exercise testing with its inherent delay in moving patients postexercise for imaging in the positron camera.Because pharmacologic stress testing has been increasing over time, Argulian et al 4 sought to determi...